CD274 and cancer: Feng noted that 59.1%, 47.0%, and 60.6% of patients were found with positive PD-L1 expression in cancer cells, positive PD-L1 expression in TILs, and positive PD-1 expression in TILs with a cut-off value of 10%, respectively.